Barrambie
Event
NMT announced successful smelter trials for is Barrambie product;
Impact
We view Barrambie as non-core; However, it has the potential to carry meaningful value for shareholders; We expect financing via a BOOT (ie minimal capital requirement from NMT) and probably an eventual divestment; Our speculative valuation for Barrambie is A$90m (15cps) on our base estimates (US$168/t selling prices) but increases to A$1b (>$1.50/sh) based on spot prices (we estimate around US$260/t); Selling price assumptions are speculative at this point (given the product mix uncertainty), but we expect clarification in the PFS and will tighten our valuation assumption for Barrambie then;
https://www.neometals.com.au/wp-content/uploads/2022/11/NMT_04Nov22.pdf
- Forums
- ASX - By Stock
- General Neometals related news
Barrambie Event NMT announced successful smelter trials for is...
Featured News
Add NMT (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.2¢ |
Change
0.001(1.10%) |
Mkt cap ! $70.78M |
Open | High | Low | Value | Volume |
9.1¢ | 9.3¢ | 9.1¢ | $118.9K | 1.290M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 428729 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.3¢ | 41610 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 428729 | 0.092 |
3 | 96346 | 0.091 |
3 | 353180 | 0.089 |
6 | 341381 | 0.088 |
3 | 221482 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 187000 | 4 |
0.095 | 173629 | 1 |
0.096 | 210514 | 2 |
0.097 | 157657 | 4 |
0.098 | 170000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NMT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online